Factors that guide clinical decisions for empiric and directed P. aeruginosa therapy include
the epidemiology, the patient's risk factors, the site of infection, and the available treatment …

Bronchiectasis is a complex, chronic respiratory condition, characterized by frequent cough
and exertional dyspnea due to a range of conditions that include inherited mucociliary …

Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Chronic respiratory diseases have collectively become a major public health concern and
have now taken form as one of the leading causes of mortality worldwide. Most chronic …

Simple Summary This commentary focuses on the methods currently available to test the
efficacy and safety of new orally inhaled drugs for the treatment of uncurable respiratory …

Inhaled antibiotic nanoparticles have emerged as an effective strategy to control infection in
bronchiectasis lung owed to their mucus-penetrating ability. Using ciprofloxacin (CIP) as the …

Introduction Microbial resistance is a severe problem for clinical practice due to misuse of
antibiotics that promotes the development of surviving strategies by bacteria and fungi …

Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system
dysregulation and impaired airway clearance cause mucus accumulation and consequent …

Chronic wet cough for longer than 4 weeks is a hallmark of chronic suppurative lung
diseases (CSLD), including protracted bacterial bronchitis (PBB), and bronchiectasis in …

People with cystic fibrosis (CF) are highly susceptible to bacterial infections of the airways.
By adulthood, chronic Pseudomonas aeruginosa (Pa) is the most prevalent infective …